Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
100.00
-1.50 (-1.48%)
Apr 2, 2025, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 12.61 billion as of April 4, 2025. Its market cap has decreased by -44.80% in one year.
Market Cap
12.61B
Enterprise Value
10.52B
Revenue
32.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
100.00
Market Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 12.61B, an increase of 42.17%. That is a compound annual growth rate of 4.41%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 178.51B |
Caliway Biopharmaceuticals | 120.14B |
Bora Pharmaceuticals Co., LTD. | 71.17B |
Lotus Pharmaceutical | 61.56B |
Oneness Biotech | 33.46B |
Lumosa Therapeutics | 29.98B |
Pegavision | 28.08B |
Center Laboratories | 27.41B |